|Patient Age Group||Adult|
|Tidal Volume||Pediatric: 20~300 mL (increments of 1 mL),Adult: 100~2000 mL (increments of 10 mL)|
The PB-760 ventilator is developed with features that can meet all your needs. It not only provides advanced ventilation modes and functionality for patients ranging from infant to adult, but also features a modern, easy-to-use interface to enhance the efficiency of your clinical workflow.
Thanks to the intuitive user interface, it allows quick and easy control over ventilator parameters and settings. The 12.1 inch screen can display up to 4 simultaneous waveforms or 2 loops. With a smartly designed user interface that combines a touch screen with direct access knobs, users can quickly learn to navigate the 760 and put all of its features into clinical use.
PB ventilator supports invasive, non-invasive ventilation and high flow O2 therapy, which can fulfill different clinical needs. It supports multiple advanced ventilation modes, such as Duolevel, APRV, PRVC and PRVC-SIMV. Mindray’s leading gas analysis technology can be integrated to enable EtCO2 monitoring.
The PB-760 also ensures data continuity by connecting to Mindray patient monitors through the BeneLink and e-Gateway modules. In this way, the ventilation data can be transferred seamlessly to the HIS and CIS systems with ease.
The optional C3 compressor can be integrated to secure ventilation in an environment without central gas supply. The PB can also be configured for mounting on a trolley or a pendant to further adapt to different clinical scenarios.
|Model Name/Number||Evita 4|
|Patient Age Group||Adult|
The Dräger Evita 4 is a ventilator for every patient population. The Evita 4 was designed to meet the demanding requirements of the ICU environment by improving the interactions between patient, ventilator and clinician. The functional touch screen continually provides the clinician information on ventilator settings, patient measurements and advanced trending capabilities which enhances the operation of the device. Unique features and modalities such as AutoFlow™ and APRV are standard on all Evita 4 ventilators.One ventilator for every patient population
Neonatal, pediatric, adult – Evita 4 can be used to ventilate any patient category, reducing the amount of staff training required and ensuring greater resource flexibility.
The neonatal option, NeoFlow™, offers flow measurement at the Y-piece for precise volume and leak monitoring with accurate, responsive triggering to patient effort.Intuitive user interface
Configurable trends, loops, measured values, curves and logbook are displayed on the full-color screen for a complete customized overview of the ventilation therapy. The user-friendly display shows only the active control elements to ensure immediate recognition of the required settings. The robust touch screen combines highly flexible operation with direct access to rotary knobs and keys.Excellent weaning performance
PCV+/ BIPAPTM*, the universal mode for ventilation and weaning, gives a patient the freedom to breathe spontaneously at any time, reducing the need for sedation and invasiveness of ventilation to optimize the patient's ability to wean off the ventilator. Automatic Tube Compensation (ATC™) gives a patient the feeling of virtual extubation by eliminating the work involved in breathing through an endotracheal tube, improving the weaning process.Conventional and mask ventilation
Mask ventilation can complement the weaning process by reducing the reintubation rate or even preventing intubation in the first place. The fact that Evita 4 offers the alternative of mask ventilation (NIV) means you only need one device for conventional and non-invasive ventilation.Upgradeability
Evita 4 is based on a concept of innovative continuity. The device's modular design ensures upgradeability and upward compatibility while the user interface and sensors, for example, are based on the continuity principle to guarantee a high degree of familiarity.A record of innovation
The Evita 4 story has been marked by a series of advances in ventilation therapy, ATC was introduced in 1997 to achieve virtual extubation, NeoFlow in 1998 for neonatal ventilation, and NIV in 2001 to make mask and conventional ventilation possible from a single device.